TY - JOUR
T1 - Dichotomy in FcγRIIB deficiency and autoimmune-prone SLAM haplotype clarifies the roles of the Fc receptor in development of autoantibodies and glomerulonephritis
AU - Kanari, Yasuyoshi
AU - Sugahara-Tobinai, Akiko
AU - Takahashi, Haruka
AU - Inui, Masanori
AU - Nakamura, Akira
AU - Hirose, Sachiko
AU - Takai, Toshiyuki
N1 - Funding Information:
We thank Masato Nose (Tohoku Univ. Graduate School of Medicine) for the pathological analysis and Nicholas Halewood for the editorial assistance. This work was supported by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Global Center of Excellence Program for Innovative Therapeutic Development Towards the Conquest of Signal Transduction Diseases with Network Medicine.
Publisher Copyright:
© Kanari et al.
PY - 2014/10/24
Y1 - 2014/10/24
N2 - Background: The significance of a unique inhibitory Fc receptor for IgG, FcγRIIB (RIIB), in the prevention of spontaneous production of autoantibodies remains controversial, due mainly to the fact that the locus is adjacent to the autoimmune-related locus harboring the genes coding for signaling lymphocyte activation molecules, making it difficult to isolate the effect of RIIB deletion from that of in gene-targeted mice. Our objective was to determine the influence of deletion on the spontaneous development of autoimmune diseases and to compare it with that of potentially pathogenic . Results: We established two congenic C57BL/6 (B6) strains, one with the deletion and the other with , by backcrossing 129/SvJ-based -deficient mice into the B6 genetic background extensively. The RIIB deficiency indeed led to the production and/or accumulation of a small amount of anti-nuclear autoantibodies (ANAs) and to weak IgG immune-complex deposition in glomeruli without any obvious manifestation of lupus nephritis. In contrast, pathogenic in the B6 genetic background induced ANAs but no IgG immune-complex deposition in the kidneys. Naïve mice but not RIIB-deficient mice exhibited hyperplasia of splenic germinal centers. Conclusion: The present results clarify the roles of RIIB in preventing production and/or accumulation of a small amount of ANAs, and development of glomerulonephritis. The combined effects of RIIB deletion and pathogenic SLAM can lead to severe lupus nephritis in the B6 genetic background.
AB - Background: The significance of a unique inhibitory Fc receptor for IgG, FcγRIIB (RIIB), in the prevention of spontaneous production of autoantibodies remains controversial, due mainly to the fact that the locus is adjacent to the autoimmune-related locus harboring the genes coding for signaling lymphocyte activation molecules, making it difficult to isolate the effect of RIIB deletion from that of in gene-targeted mice. Our objective was to determine the influence of deletion on the spontaneous development of autoimmune diseases and to compare it with that of potentially pathogenic . Results: We established two congenic C57BL/6 (B6) strains, one with the deletion and the other with , by backcrossing 129/SvJ-based -deficient mice into the B6 genetic background extensively. The RIIB deficiency indeed led to the production and/or accumulation of a small amount of anti-nuclear autoantibodies (ANAs) and to weak IgG immune-complex deposition in glomeruli without any obvious manifestation of lupus nephritis. In contrast, pathogenic in the B6 genetic background induced ANAs but no IgG immune-complex deposition in the kidneys. Naïve mice but not RIIB-deficient mice exhibited hyperplasia of splenic germinal centers. Conclusion: The present results clarify the roles of RIIB in preventing production and/or accumulation of a small amount of ANAs, and development of glomerulonephritis. The combined effects of RIIB deletion and pathogenic SLAM can lead to severe lupus nephritis in the B6 genetic background.
KW - Autoantibody production
KW - Autoimmune disease
KW - B cells
KW - Inhibitory receptor
KW - Myeloid cells
KW - Systemic lupus erythematosus
UR - http://www.scopus.com/inward/record.url?scp=84923853999&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923853999&partnerID=8YFLogxK
U2 - 10.1186/s12865-014-0047-y
DO - 10.1186/s12865-014-0047-y
M3 - Article
C2 - 25339546
AN - SCOPUS:84923853999
SN - 1471-2172
VL - 15
JO - BMC Immunology
JF - BMC Immunology
IS - 1
M1 - 47
ER -